Checked
Preserve Access to Affordable Generics and Biosimilars Act
S. 142, 118th Congress
- Status
- In committee
- Introduced
- 01/30/2023
- Cosponsors
- 10
- Latest action
- 03/01/2023
About this bill
- Official title
- Preserve Access to Affordable Generics and Biosimilars Act
- Sponsor
- Amy Klobuchar (D-MN)
- Introduced in
- Senate
- Policy area
- Health
- Committees
- Judiciary Committee
- Latest action
- Placed on Senate Legislative Calendar under General Orders. Calendar No. 20.
Actions
Newest first
- 03/01/2023 · Senate
Placed on Senate Legislative Calendar under General Orders. Calendar No. 20.
- 03/01/2023 · Senate
Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
- 02/09/2023 · Senate
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
- 01/30/2023 · Senate
Read twice and referred to the Committee on the Judiciary.
- 01/30/2023
Introduced in Senate
Subjects: Administrative law and regulatory procedures, Civil actions and liability, Competition and antitrust, Contracts and agency, Federal Trade Commission (FTC), Intellectual property, Judicial review and appeals, Licensing and registrations, Manufacturing, Marketing and advertising, Prescription drugs.
Source: U.S. Government Publishing Office, GovInfo Bill Status; Congressional Research Service summaries · Last updated 03/01/2023